Overview
This page compares Injective and USDA with live PEPS metrics. Rankings (#99 vs #262) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | INJ | USDA |
|---|---|---|
| Price | $4.98 | $1,853.59 |
| Market Cap | $490.41M | $96.18M |
| FDV | — | — |
| Volume 24h | $2.75M | $1.92 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 262.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | USDA |
|---|---|---|
| 1H | — | — |
| 24H | +1.20% | +0.00% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | USDA |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.07 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 67.00 |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across Injective and USDA, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | INJ | USDA |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
USDA
Pros and cons
Pros of Injective
- Higher ranking for Injective can translate into tighter spreads on major venues.
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
Cons of Injective
- Regulatory or macro headlines can hit Injective harder simply because it is more visible.
- When dominance narratives fade, Injective can lag hotter rotation names.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
Pros of USDA
- Narrative optionality around USDA can reprice quickly when catalysts appear.
- Active volume bursts on USDA sometimes precede sharper tactical moves.
- USDA can offer higher relative beta when market attention rotates toward its niche.
- Diversifying versus Injective with USDA can change portfolio factor exposure.
Cons of USDA
- Smaller book depth versus large caps can increase slippage for USDA.
- Weaker market-cap standing may leave USDA more exposed to liquidity droughts.
- Relative underperformance versus Injective can persist through entire market regimes.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. Injective and USDA can alternate leadership as macro liquidity and narrative rotate.
AI summary
This AI-assisted summary starts from live PEPS fields. Injective holds market-cap $490.41M and rank #99; USDA shows $96.18M and #262. Where liquidity and flow matter, watch Injective. Where durability matters, watch Injective. AI composite scores (47.20/57.90) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, Injective or USDA?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or USDA?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and USDA.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.